CABR
Caring Brands, Inc.
Price Chart
Latest Quote
$1.20
-0.08 (-6.61%)
Current Price
| Previous Close | $1.28 |
| Open | $1.32 |
| Day High | $1.34 |
| Day Low | $1.20 |
| Volume | 133,523 |
Stock Information
| Shares Outstanding | 9.09M |
| Cash Equivalents | $2.03M |
| Revenue | $3K |
| Net Income | $-9.59M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $10.91M |
| EPS (TTM) | $-0.69 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $13.85M |
| Sales | $3K |
| Income | $-9.59M |
| Book/sh | $-0.23 |
| Cash/sh | $0.22 |
| Employees | 4 |
Financial Ratios
| Quick Ratio | 5.29 |
| Current Ratio | 5.65 |
Returns & Margins
| ROE | -282.84% |
| Gross Margin | 56.48% |
| Operating Margin | -166321.24% |
Ownership
| Insider Ownership | 89.09% |
| Institutional Ownership | 2.26% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 3972.98 |
| P/B | -5.31 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.18 |
| SMA50 | $1.11 |
| RSI | 54.64 |
| ATR | 0.1324 |
| Shares Float | 1.54M |
| Short Float | 0.27% |
| Short Ratio | 0.22 |
| Rel Volume | 1.61 |
Performance History
| Week | +10.09% |
| Month | +30.43% |
| Quarter | +29.31% |
| 6 Months | +28.76% |
| YTD | +20.00% |
| 10 Years | +44.06% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.20 | 148,400 |
| 2026-06-17 | $1.28 | 109,300 |
| 2026-06-16 | $1.33 | 161,000 |
| 2026-06-15 | $1.20 | 73,100 |
| 2026-06-12 | $1.13 | 41,900 |
| 2026-06-11 | $1.09 | 30,400 |
| 2026-06-10 | $1.10 | 52,600 |
| 2026-06-09 | $1.20 | 19,600 |
| 2026-06-08 | $1.20 | 291,200 |
| 2026-06-05 | $1.26 | 95,600 |
| 2026-06-04 | $1.28 | 71,000 |
| 2026-06-03 | $1.18 | 81,900 |
| 2026-06-02 | $1.25 | 76,100 |
| 2026-06-01 | $1.30 | 116,100 |
| 2026-05-29 | $1.11 | 66,900 |
| 2026-05-28 | $1.16 | 114,100 |
| 2026-05-27 | $1.08 | 11,300 |
| 2026-05-26 | $1.17 | 73,300 |
| 2026-05-22 | $1.15 | 121,200 |
| 2026-05-21 | $0.99 | 87,100 |
| 2026-05-20 | $0.89 | 91,800 |
| 2026-05-19 | $0.92 | 251,700 |
About Caring Brands, Inc.
Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products. It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; and CB-101 (Eczema Treatment) for atopic dermatitis (eczema). The company also offers NoStingz for the protection from jellyfish, sea lice, and UVA/UVB rays; and GoldN for Ebola diagnostics, as well as provides vitiligo solutions and women's sexual wellness products. Caring Brands, Inc., was incorporated in 2020 and is based in Fort Pierce, Florida.
đ° Latest News
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $1,873 | $2,072 | $118,874 |
| Cost Of Revenue | $1,873 | $2,072 | $118,874 |
| Total Revenue | $4,215 | $465 | $20,421 |
| Operating Revenue | $4,215 | $465 | $20,421 |
| Expenses | |||
| Total Expenses | $3,389,240 | $1,527,859 | $171,815 |
| Other Income Expense | $-2,874,000 | - | $23,308 |
| Other Non Operating Income Expenses | $1,000 | - | - |
| Net Non Operating Interest Income Expense | $-19,166 | $9,963 | $0 |
| Total Other Finance Cost | $19,166 | $-9,963 | - |
| Operating Expense | $3,387,367 | $1,525,787 | $52,941 |
| General And Administrative Expense | $3,087,367 | - | - |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-6,278,191 | $-1,517,431 | $-128,086 |
| Net Interest Income | $-19,166 | $9,963 | $0 |
| Normalized Income | $-3,403,191 | $-1,517,431 | $-151,394 |
| Net Income From Continuing And Discontinued Operation | $-6,278,191 | $-1,517,431 | $-128,086 |
| Total Operating Income As Reported | $-5,935,025 | - | - |
| Net Income Common Stockholders | $-6,278,191 | $-1,517,431 | $-128,086 |
| Net Income | $-6,278,191 | $-1,517,431 | $-128,086 |
| Net Income Including Noncontrolling Interests | $-6,278,191 | $-1,517,431 | $-128,086 |
| Net Income Continuous Operations | $-6,278,191 | $-1,517,431 | $-128,086 |
| Pretax Income | $-6,278,191 | $-1,517,431 | $-128,086 |
| Special Income Charges | $-2,875,000 | - | $23,308 |
| Operating Income | $-3,385,025 | $-1,527,394 | $-151,394 |
| Depreciation Amortization Depletion Income Statement | $300,000 | - | - |
| Depreciation And Amortization In Income Statement | $300,000 | - | - |
| Gross Profit | $2,342 | $-1,607 | $-98,453 |
| Per Share | |||
| Diluted EPS | $-0.46 | $-0.11 | $-0.01 |
| Basic EPS | $-0.46 | $-0.11 | $-0.01 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-210,025 | $-1,377,394 | $-172,502 |
| Total Unusual Items | $-2,875,000 | - | $23,308 |
| Total Unusual Items Excluding Goodwill | $-2,875,000 | - | $23,308 |
| Reconciled Depreciation | $300,000 | $150,000 | $2,200 |
| EBITDA (Bullshit earnings) | $-3,085,025 | $-1,377,394 | $-149,194 |
| EBIT | $-3,385,025 | $-1,527,394 | $-151,394 |
| Diluted Average Shares | $13,565,096 | $14,110,000 | $11,737,251 |
| Basic Average Shares | $13,565,096 | $14,110,000 | $11,737,251 |
| Diluted NI Availto Com Stockholders | $-6,278,191 | $-1,517,431 | $-128,086 |
| Other Special Charges | $-175,000 | - | - |
| Write Off | $500,000 | - | - |
| Impairment Of Capital Assets | $2,550,000 | - | - |
| Selling General And Administration | $3,087,367 | $721,214 | - |
| Other Gand A | $1,078,973 | - | - |
| Salaries And Wages | $2,008,394 | - | - |
| Gain On Sale Of Ppe | - | - | $23,308 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $2,091,324 | $841,376 | $-265,774 |
| Total Assets | $2,326,818 | $3,877,481 | $22,915 |
| Total Non Current Assets | $0 | $3,350,000 | $0 |
| Goodwill And Other Intangible Assets | $0 | $2,850,000 | $0 |
| Current Assets | $2,326,818 | $527,481 | $22,915 |
| Other Current Assets | $124,779 | $44,794 | - |
| Inventory | $12,807 | $13,689 | $0 |
| Cash Cash Equivalents And Short Term Investments | $2,189,232 | $468,998 | $18,161 |
| Cash And Cash Equivalents | $2,189,232 | $468,998 | $18,161 |
| Cash Financial | $2,189,232 | $468,998 | $18,161 |
| Investmentin Financial Assets | - | $500,000 | - |
| Other Intangible Assets | - | $2,850,000 | - |
| Prepaid Assets | - | $44,794 | $4,400 |
| Receivables | - | $0 | $354 |
| Accounts Receivable | - | $0 | $354 |
| Debt | |||
| Total Debt | $58,650 | - | $266,955 |
| Long Term Debt And Capital Lease Obligation | $58,650 | - | $266,955 |
| Long Term Debt | $58,650 | - | $266,955 |
| Net Debt | - | - | $248,794 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $235,494 | $186,105 | $288,689 |
| Total Non Current Liabilities Net Minority Interest | $58,650 | $0 | $266,955 |
| Current Liabilities | $176,844 | $186,105 | $21,734 |
| Payables And Accrued Expenses | $176,844 | $186,105 | $21,734 |
| Interest Payable | $4,744 | $0 | - |
| Payables | $170,351 | $169,432 | $20,665 |
| Accounts Payable | $170,351 | $169,432 | $20,665 |
| Equity | |||
| Common Stock Equity | $2,091,324 | $3,691,376 | $-265,774 |
| Total Equity Gross Minority Interest | $2,091,324 | $3,691,376 | $-265,774 |
| Stockholders Equity | $2,091,324 | $3,691,376 | $-265,774 |
| Other Equity Interest | $-800 | - | - |
| Retained Earnings | $-7,140,982 | $-862,791 | $-265,774 |
| Long Term Equity Investment | $0 | $500,000 | $0 |
| Other | |||
| Ordinary Shares Number | $14,761,925 | $14,110,000 | $14,110,000 |
| Share Issued | $14,761,925 | $14,110,000 | $14,110,000 |
| Tangible Book Value | $2,091,324 | $841,376 | $-265,774 |
| Invested Capital | $2,149,974 | $3,691,376 | $1,181 |
| Working Capital | $2,149,974 | $341,376 | $1,181 |
| Total Capitalization | $2,149,974 | $3,691,376 | $1,181 |
| Additional Paid In Capital | $9,135,341 | $4,541,057 | $0 |
| Capital Stock | $97,765 | $13,110 | $0 |
| Common Stock | $97,765 | $13,110 | $0 |
| Preferred Stock | $0 | $0 | $0 |
| Current Accrued Expenses | $6,493 | $16,673 | $1,069 |
| Investments And Advances | $0 | $500,000 | $0 |
| Available For Sale Securities | - | $500,000 | - |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-1,692,258 | $-823,991 | $-58,632 |
| Operating Activities | |||
| Operating Cash Flow | $-1,692,258 | $-823,991 | $-58,632 |
| Cash Flow From Continuing Operating Activities | $-1,692,258 | $-823,991 | $-58,632 |
| Operating Gains Losses | $675,000 | - | $-23,308 |
| Investing Activities | |||
| Investing Cash Flow | $0 | $608,596 | $39,100 |
| Cash Flow From Continuing Investing Activities | $0 | - | $39,100 |
| Net Other Investing Changes | - | - | $39,100 |
| Financing Activities | |||
| Issuance Of Capital Stock | $3,242,492 | $0 | $0 |
| Financing Cash Flow | $3,412,492 | $666,232 | $15,390 |
| Cash Flow From Continuing Financing Activities | $3,412,492 | $666,232 | $15,390 |
| Net Common Stock Issuance | $3,242,492 | $0 | $0 |
| Common Stock Issuance | $3,242,492 | $0 | $0 |
| Other | |||
| Repayment Of Debt | $-120,000 | - | $0 |
| Issuance Of Debt | $290,000 | $666,232 | $15,390 |
| End Cash Position | $2,189,232 | $468,998 | $18,161 |
| Beginning Cash Position | $468,998 | $18,161 | $22,303 |
| Changes In Cash | $1,720,234 | $450,837 | $-4,142 |
| Net Issuance Payments Of Debt | $170,000 | $666,232 | $15,390 |
| Net Long Term Debt Issuance | $170,000 | $666,232 | $15,390 |
| Long Term Debt Payments | $-120,000 | - | - |
| Long Term Debt Issuance | $290,000 | $666,232 | $15,390 |
| Net Business Purchase And Sale | $0 | - | - |
| Sale Of Business | $0 | - | - |
| Change In Working Capital | $-184,384 | $143,440 | $90,562 |
| Change In Payables And Accrued Expense | $-105,281 | $178,234 | $13,703 |
| Change In Accrued Expense | $-10,180 | $37,353 | $-5,008 |
| Change In Payable | $-95,101 | $140,881 | $18,711 |
| Change In Account Payable | $-95,101 | $140,881 | $18,711 |
| Change In Prepaid Assets | $-79,985 | $-35,148 | $-4,400 |
| Change In Inventory | $882 | $0 | $81,241 |
| Change In Receivables | $0 | $354 | $18 |
| Changes In Account Receivables | $0 | $354 | $18 |
| Other Non Cash Items | $6,667 | - | - |
| Stock Based Compensation | $1,238,650 | $400,000 | $0 |
| Asset Impairment Charge | $2,550,000 | - | - |
| Depreciation Amortization Depletion | $300,000 | $150,000 | $2,200 |
| Depreciation And Amortization | $300,000 | $150,000 | $2,200 |
| Gain Loss On Investment Securities | $500,000 | - | - |
| Net Income From Continuing Operations | $-6,278,191 | $-1,517,431 | $-128,086 |
| Interest Paid Supplemental Data | - | - | $0 |
| Income Tax Paid Supplemental Data | - | - | $0 |
| Net Short Term Debt Issuance | - | - | $0 |
| Short Term Debt Payments | - | - | $0 |
| Net Investment Purchase And Sale | - | - | $0 |
| Purchase Of Investment | - | - | $0 |
| Amortization Cash Flow | - | - | $0 |
| Amortization Of Intangibles | - | - | $0 |
| Depreciation | - | - | $2,200 |
Fetched: 2026-06-18